Literature DB >> 10934069

Quality of dyspnea in bronchoconstriction differs from external resistive loads.

M L Moy1, J Woodrow Weiss, D Sparrow, E Israel, R M Schwartzstein.   

Abstract

To test the hypothesis that patients perceive the same quality of dyspnea during mild bronchoconstriction and external resistive loads, we studied subjects with asthma under two conditions: (1) during methacholine bronchoprovocation to mimic the bronchospasm of mild asthma and (2) while breathing on a circuit to which was added a range of external resistors to mimic the mechanical load of mild asthma. During each of these stimuli, respiratory variables, overall dyspnea intensity on a modified Borg scale, and the qualitative descriptors of breathlessness from a 19-item questionnaire were assessed. The "chest tightness" and "constriction" responses were significantly more frequent in the methacholine trials as compared with the external load trials (p < 0.0001). The "chest tightness" or "constriction" response was chosen during 92% of the 26 trials of methacholine bronchoconstriction compared with 3% of the 72 trials of breathing against the external resistors. Changes in functional residual capacity were not significantly different between the two conditions. We conclude that in mild asthma, the sensation of chest tightness is distinct from the sensation of work and effort and is not attributable to the mechanical load imposed on the respiratory system.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10934069     DOI: 10.1164/ajrccm.162.2.9907138

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  13 in total

Review 1.  [Acute dyspnoea].

Authors:  U Wagner; C Vogelmeier
Journal:  Internist (Berl)       Date:  2005-09       Impact factor: 0.743

2.  Reliability and predictors of resistive load detection in children with persistent asthma: a multivariate approach.

Authors:  Andrew Harver; Allison Dyer; Jennifer L Ersek; Harry Kotses; C Thomas Humphries
Journal:  J Asthma       Date:  2014-09-17       Impact factor: 2.515

3.  Effects of feedback on the perception of inspiratory resistance in children with persistent asthma: a signal detection approach.

Authors:  Andrew Harver; Harry Kotses; Jennifer Ersek; Charles Thomas Humphries; William S Ashe; Hugh R Black
Journal:  Psychosom Med       Date:  2013-09-27       Impact factor: 4.312

4.  Validation of a three-factor measurement model of dyspnea in hospitalized adults with heart failure.

Authors:  Mark B Parshall; Adam C Carle; Unchalee Ice; Robert Taylor; Joyce Powers
Journal:  Heart Lung       Date:  2011-07-27       Impact factor: 2.210

5.  An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.

Authors:  Mark B Parshall; Richard M Schwartzstein; Lewis Adams; Robert B Banzett; Harold L Manning; Jean Bourbeau; Peter M Calverley; Audrey G Gift; Andrew Harver; Suzanne C Lareau; Donald A Mahler; Paula M Meek; Denis E O'Donnell
Journal:  Am J Respir Crit Care Med       Date:  2012-02-15       Impact factor: 21.405

Review 6.  Cough, pain and dyspnoea: similarities and differences.

Authors:  Richard H Gracely; Bradley J Undem; Robert B Banzett
Journal:  Pulm Pharmacol Ther       Date:  2007-01-10       Impact factor: 3.410

Review 7.  [Heart and lungs : cardinal symptom dyspnea].

Authors:  M O Henke; C F Vogelmeier
Journal:  Herz       Date:  2013-05       Impact factor: 1.443

Review 8.  The multiple dimensions of dyspnea: review and hypotheses.

Authors:  Robert W Lansing; Richard H Gracely; Robert B Banzett
Journal:  Respir Physiol Neurobiol       Date:  2008-07-25       Impact factor: 1.931

9.  [Differential diagnoses of dyspnoea].

Authors:  A R Koczulla; C Vogelmeier
Journal:  Internist (Berl)       Date:  2007-12       Impact factor: 0.743

Review 10.  Physiologic changes and clinical correlates of advanced dyspnea.

Authors:  Sean A Gilman; Robert B Banzett
Journal:  Curr Opin Support Palliat Care       Date:  2009-06       Impact factor: 2.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.